Entities / Company
Avita Medical.
Australian public company
- Reports this week
- 0
- Active events
- 0
- Connections
- 32
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
One to three months ago
-
Avita Medical and Zynex, both small-cap regenerative medicine companies, traded on the Nasdaq stock exchange.Some support2 reports
-
PermeaDerm offers a 70% economic advantage over allograft.Some support1 report
-
Avita Medical received multiple international regulatory approvals for its product RECELL on August 1, 2026, including FDA clearance for U.S. use and CE marking in Europe.Some support2 reports
Gone quiet
No new reports in 90+ days-
Avita Medical achieved CE marking for its RECELL GO device in the U.K. on June 18, coinciding with company data presentations and annual meetings in Nottingham.Some support1 report
-
Avita Medical traded on the Nasdaq stock exchange and filed disclosures with the SEC on June 10.Some support2 reports
-
Trump's pledge to unleash oil and gas benefits stocks, with Avita Medical mentioned as an involved entity.Some support2 reports
-
Avita Medical operates as a therapeutic acute wound care company.Speculative1 report
-
Michael Tarnoff was appointed to the Avita Medical Board of Directors on August 7, 2025. Lou Panaccio served as Board Chair for 10 years, while Cary Vance assumed the role of Board Chair.Some support1 report
-
Avita Medical received FDA approval for its RECELL System, granting it exclusive U.S. market rights.Some support4 reports
-
Avita Medical raised capital from Australian investors and issued CDIs quoted on the ASX on August 12, 2025.Some support1 report
-
Research findings by Avita Medical and Victoria Miles were presented at a congress in Berlin.Some support6 reports
No events began in the chosen period. Widen it, or reset.
Around Avita Medical this week
News at the entities that move Avita Medical most-
SEC StructuralCNBC reports on FED rate decisions and their impact on the Main Street economy and SEC yields.Moves Avita Medical
-
FDA StructuralFDA conducted surprise raids and inspections in Bihar state, directed by state government officials.Moves Avita Medical
-
Europe StructuralHill and Carl Cannon offer critiques and alternatives regarding European welfare state and economic issues.Moves Avita Medical
-
Nasdaq StructuralVMware's stock performance was tracked on the Nasdaq exchange on October 25, 2026.Moves Avita Medical
-
TD Cowen Mentioned togetherDatadog saw institutional investment changes tracked by the SEC and received a buy rating from TD Cowen.Moves Avita Medical
-
MarketBeat Mentioned togetherMarketBeat released analyst recommendations for small-cap communication services companies Optimum Communications and Criteo.Moves Avita Medical
Connections
The 8 strongest of 32, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
The FDA formally regulates and approves Avita Medical's medical devices, granting them market access.
-
Europe Structural
Avita Medical's market access and operation in Europe are contingent upon receiving formal CE mark regulatory approval.
-
Nasdaq Structural
Avita Medical is formally listed and trades its shares on the Nasdaq stock exchange.
-
SEC Structural
Avita Medical operates under the formal regulatory oversight of the SEC, requiring company disclosures.
-
TD Cowen Mentioned together
TD Cowen provided favorable investment coverage, including buy ratings and price objective increases, for Avita Medical.
-
Stoke Mandeville Hospital Structural
Stoke Mandeville Hospital utilizes Avita Medical's medical system, establishing a functional supply chain dependency.
-
Zynex Operational
Both companies function as small-cap competitors within the specialized healthcare market.
-
MarketBeat Mentioned together
MarketBeat reports financial metrics, including consensus ratings and target prices, for Avita Medical.
History
Events by the month they beganSeptember 2026
1 eventAugust 2026
3 events- Avita Medical received a buy rating reaffirmation from TD Cowen, alongside MarketBeat consensus ratings and SEC insider buying disclosures.
- PermeaDerm offers a 70% economic advantage over allograft.
- Avita Medical received multiple international regulatory approvals for its product RECELL on August 1, 2026, including FDA clearance for U.S. use and CE marking in Europe.
June 2026
8 events- Avita Medical achieved CE marking for its RECELL GO device in the U.K. on June 18, coinciding with company data presentations and annual meetings in Nottingham.
- Avita Medical traded on the Nasdaq stock exchange and filed disclosures with the SEC on June 10.
- Trump's pledge to unleash oil and gas benefits stocks, with Avita Medical mentioned as an involved entity.
- Avita Medical operates as a therapeutic acute wound care company.
- Michael Tarnoff was appointed to the Avita Medical Board of Directors on August 7, 2025. Lou Panaccio served as Board Chair for 10 years, while Cary Vance assumed the role of Board Chair.
- Avita Medical received FDA approval for its RECELL System, granting it exclusive U.S. market rights.
- Avita Medical raised capital from Australian investors and issued CDIs quoted on the ASX on August 12, 2025.
- Research findings by Avita Medical and Victoria Miles were presented at a congress in Berlin.